Ultragenyx Pharmaceutical (RARE) traded up 2.75 % during a 24 hours period ending at 03:52 AM Central Europe on Wednesday 28th. One Ultragenyx Pharmaceutical stock can currently be bought for about USD 16.75 on popular exchanges. Current supply of Ultragenyx Pharmaceutical stocks is 98 mn. Ultragenyx Pharmaceutical has a current market capitalization of USD 1.6 bn and approximately USD 48.6 mn worth of Ultragenyx Pharmaceutical was traded on exchanges in the last 24 hours. Since last month end, Ultragenyx Pharmaceutical has traded 11.59 % up. Simple moving average of last 200 days is at USD 23.04. The highest price of past 52 weeks was recorded at USD 39.89 on 12/08/2025. 52 weeks low was at USD 12.73 on 09/16/2026.
Here is how related stocks have performed in the past 24 hours:
Olin (OLN) traded up 1.79 % and now trades at USD 16.56. Olin has a market capitalisation of USD 1.9 bn.
Trevi Therapeutics (TRVI) traded down -0.79 % and now trades at USD 13.35. Trevi Therapeutics has a market capitalisation of USD 1.8 bn.
Spectrum Brands (SPB) traded up 0.43 % and now trades at USD 80.69. Spectrum Brands has a market capitalisation of USD 1.9 bn. Current price/earnings ratio for Spectrum Brands is 23.73.
Firstsun Capital (FSUN) traded down -0.03 % and now trades at USD 40.09. Current market capitalisation for Firstsun Capital is USD 1.9 bn.
Mineralys Therapeutics (MLYS) traded up 0.05 % and now trades at USD 21.13. Mineralys Therapeutics has a market capitalisation of USD 1.8 bn.
About Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical Inc. is a biotechnology service provider based in Novato, United States. The company specializes in developing therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases.